To evaluate if the methylation status of CG probesets within both promoter and body regions contributes to the regulation of SLC22A17 expression, correlation analysis between CG probesets methylation and gene expression was performed for each tumor type (Figure 13A). This evidence concerns the gene SLC22A17 and neoplasm.